215666 RESULTS

Intepirdine Joins the Ranks of Failed Alzheimer’s Drugs

RESEARCH NEWS 2017-09-26 Research News Today, Axovant Sciences in Basel, Switzerland, released topline results from its Phase 3 MINDSET trial of the 5-HT6 inhibitor intepirdine. The drug failed to improve cognition or activities of daily living relative to placebo in patients ...

Call for ADRC Pilot Project Proposals

GRANT Monday, September 25, 2017- 22:00 UW Alzheimer's Disease Research Center The UW ADRC will fund at least two awards for junior researchers of up $30,000 each, and one award of up to $75,000, which is also open to established researchers new to the ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From